Loading…

Serum kynurenine levels are a novel biomarker to predict the prognosis of patients with hepatocellular carcinoma

We examined serum kynurenine levels in patients with chronic hepatitis C virus infection, and the relationship between serum kynurenine and prognosis in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C. We retrospectively analyzed 604 patients with HCC diagnosed between January 1...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2020-10, Vol.15 (10), p.e0241002-e0241002
Main Authors: Bekki, Shigemune, Hashimoto, Satoru, Yamasaki, Kazumi, Komori, Atsumasa, Abiru, Seigo, Nagaoka, Shinya, Saeki, Akira, Suehiro, Tomoyuki, Kugiyama, Yuki, Beppu, Asami, Kuroki, Tamotsu, Nakamura, Minoru, Ito, Masahiro, Yatsuhashi, Hiroshi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We examined serum kynurenine levels in patients with chronic hepatitis C virus infection, and the relationship between serum kynurenine and prognosis in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C. We retrospectively analyzed 604 patients with HCC diagnosed between January 1999 and December 2015, and 288 patients without HCC who were seen at the National Hospital Organization Nagasaki Medical Center between October 2014 and November 2017. The association between serum kynurenine and prognosis was evaluated using the Cox's proportional hazards regression analysis. Patients with HCC had significantly higher values of serum kynurenine than patients without HCC (median: 557.1 vs. 464.2 ng/mL, p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0241002